Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 66,193 | 174,017 | 57,497 | 21,988 | 21,973 |
| Cost of Goods | 9,557 | 15,214 | 6,676 | 6,483 | 6,509 |
| Gross Profit | 56,636 | 158,803 | 50,821 | 15,505 | 15,464 |
| Operating Expenses | 181,614 | 153,371 | 151,485 | 137,968 | 102,658 |
| Operating Income | -124,421 | 5,646 | -99,988 | -121,980 | -86,685 |
| Interest Expense | 12,046 | 12,175 | 11,932 | 11,859 | 2,657 |
| Other Income | 41,021 | 48,228 | 4,462 | 9,462 | 13,162 |
| Pre-tax Income | -95,446 | 41,699 | -107,458 | -124,377 | -76,180 |
| Net Income Continuous | -95,446 | 41,699 | -107,458 | -124,377 | -76,180 |
| Net Income | $-95,446 | $41,699 | $-107,458 | $-124,377 | $-76,180 |
| EPS Basic Total Ops | -1.71 | 0.75 | -2.13 | -2.83 | -1.81 |
| EPS Basic Continuous Ops | -1.71 | 0.75 | -2.13 | -2.83 | -1.81 |
| EPS Diluted Total Ops | -1.71 | 0.74 | -2.13 | -2.83 | -1.81 |
| EPS Diluted Continuous Ops | -1.71 | 0.74 | -2.13 | -2.83 | -1.81 |
| EBITDA(a) | $-108,917 | $21,008 | $-87,051 | $-113,526 | $-80,608 |